Thermal ablation offers an intriguing therapeutic option to improve local tumour control and survival in patients with early-stage non-small cell lung cancer or patients with limited metastatic disease from non-lung primaries who are not candidates for surgery, either because of poor cardiopulmonary reserve, anatomic constraints limiting resection, failure of traditional therapies, or refusal of operative approaches. The new field of interventional oncology needs adequate knowledge of the therapeutic tools, advantages and limitations of each method, when and how to apply them, as well as of the new integrative protocols that improve their efficacy. This article provides a clinical review of the role of microwave ablation therapy of primary and metastatic tumours.
Objectives of Ablation Therapy
The main objectives of ablation therapy of pulmonary tumours (and other malignancies) are:
• to eradicate all viable malignant cells in the target volume, with a safety margin to ensure complete eradication; and
• to minimise the damage to a certain targeted volume in order to provide a good functioning reserve of the rest of the lung; this is particularly important in patients with limited pulmonary function due to extensive underlying emphysema and fibrosis.
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Lung Cancer The potential advantages of local tumour ablation therapy over surgical resection include:
• selective damage;
• minimal treatment morbidity and mortality;
• less breathing impairment in patients with borderline lung function through sparing healthy lung tissue;
• repeatability;
• fairly low cost;
• excellent imaging during the procedure and for follow-up; and last but not least
• gain in quality of life with less pain, much shorter hospitalisation (whether the intervention is performed on an outpatient basis or with overnight stay) and thus quicker re-access to social life.
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Pathophysiology of Hyperthermic Ablation
Raising the tissue temperature to 45 °C for several hours results in irreversible cell damage. This cytotoxic effect can be drastically shortened down to a few minutes by increasing the temperature to up to 50-60 °C. At temperatures between 60 °C and 100 °C, almost instant coagulation of tissue is induced and manifests as irreversible damage to mitochondrial and cytosolic enzymes of the cells and to DNA. At more than 100-110 °C, tissue will vaporise and carbonise. 13 This thermobiological effect is at the core of hyperthermic ablation.
The lung has a complex structure of ventilated alveoli and bronchi in addition to blood vessels. The air-filled cavities work as heat insulators, while the enclosing capillary beds function as heat dissipaters. Air in the bronchial system is continually exchanged by ventilation and, similarly, the high blood circulation carries away heat.
The location-dependent variability of these structures can lead to a variation in thermal parameters.
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Indications for Pulmonary Ablation Therapy
The indications for local ablation of primary and metastatic lung neoplasms are similar to those established for resection, although with some modifications (see Table 1 ). It is usually applied when the number of lesions per hemithorax is five or less and the diameter of the largest lesion is less than 5 cm -however, there is institutional variability regarding these criteria. Ideally, tumours should be smaller than 3.5 cm in diameter and completely surrounded by non-tumourous lung. 6, 11, 15 Most authors think that the treatment should be offered only to patients with no evidence of extrapulmonary disease; however, there is a role for thermal ablation in pain palliation. Ablation therapy can also be applied in patients who are refractory or not amenable to conventional therapies (surgery, chemotherapy and radiation therapy)
as a result of coexistent morbidity (for example, pulmonary emphysema, liver cirrhosis, haemodialysis or another tumour).
Contraindications for ablation therapy include bleeding coagulopathy (international normalised ratio (INR) greater than 1.5 and platelet count less than 75 x 10 3 /μl).
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Complications of Pulmonary Ablation Therapy
From a procedural and technical point of view, pulmonary ablation therapy has been considered as a safe and minimally invasive method. Complications associated with it are outlined below.
Pneumothorax
In most large studies, the incidence of pneumothorax ranges from 15-25 %, which is similar to the incidence of pneumothorax after lung biopsy as reported in the literature. According to the literature, the most important risk factors include old age, chronic obstructive pulmonary disease, and deep basal and small lesions and long intrapulmonary ablation track (see Figure 1 ).
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Pulmonary Haemorrhage
Haemorrhage is a known complication in lung ablation and results from the positioning of the ablation device rather than from the ablation process. The reported incidence of haemorrhage is <1 %, but it seems to be underestimated (see Figure 2) . 12 
Pleural Effusion
A small amount of pleural effusion is usually seen during the ablation procedure, increasing in size with ablation duration and number of lesions treated. On the control erect chest radiograph post-intervention, the lateral costophrenic angle is obliterated. These effusions, sympathetic in character, do not require tapping. They usually resolve within a couple of days and are asymptomatic.
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Cavitation and Infection
Cavitation at the ablation site can develop, but it usually resolves uneventfully. Cavitation is seen significantly more frequently when the size of the lesion at one week after treatment exceeds the size of the pre-treatment lesion by 200 % or more. Some centres performing ablation therapy apply prophylactic intravenous antibiotics prior to the ablation on the day of the intervention; others even cover the day before and the day after the ablation. 
Common Minor Side Effects
Common minor side effects include pain in the puncture site area, pleuritic pain, nausea, vomiting, moderate fever, tiredness and headache.
Fever, nausea, tiredness and vomiting are the main elements of post-ablation syndrome, which is seen in about two-thirds of patients and might last for one to two weeks. In general, supportive therapy, including mild analgesics and non-steroidals, is sufficient in such cases.
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Physics of Microwave Heating
Microwaves belong to the electromagnetic waves with wavelengths in the range of 30 cm (frequency = 1 GHz) to 1 mm (300 GHz). Both RF and MW ablation are reported to show comparable ablation diameters. RF ablation typically creates ablation diameters of 2-4 cm depending on the system applied (multi-tined, internally cooled single or cluster). 22 The MW devices used in clinical practice show varying sizes of coagulation volume depending on their geometry: applicators
Lung Cancer of straight geometry are reported to achieve coagulation of up to 2.5 cm in diameter, whereas single loop-antenna applicators have been reported to result in coagulation of up to 3.5 cm in diameter. 21, 23, 24 To increase the coagulation volume, multi-applicator approaches may be used (multi-polar RF devices, multi-applicator MW devices).
A 58-year-old male patient had a history of left-sided renal cell carcinoma (RCC). He was treated by left nephrectomy. A: Computed tomography (CT) scan showing a right pleural based rounded pulmonary lesion (arrow). The lesion was histopathologically proven to be an RCC metastasis. B: CT scan during microwave (MW) ablation of the lesion (arrow). C: CT scan 24 hours post-MW ablation of the lesion, revealing ground glass opacification surrounding the lesion and veiling of its margin (arrows
With increasing ablation power, however, the danger of tissue heating in unwanted areas significantly increases in RF ablation, whereas this is not an issue in MW ablation. In RF ablation, the pathway of Vascular flow may cause a significant reduction in the effectiveness of RF ablation due to the cooling of the perivascular area, which is called the heat sink effect. 21, 23, 24 In several recent publications, the opposite effect was described for MW ablation, where a selective tracking of the ablation zone along blood vessels was discovered. Up to now, this effect has not been completely explained. It has been suggested that the presence of a vessel might cause a distortion or extension of the energy distribution pattern of the electromagnetic irradiation. It has also been suggested that the effect could possibly be due to thermally produced vapour travelling though the vessel. The increased performance of MW ablation close to vessels may reduce the local relapse rate close to liver veins, compared with RF ablation. However, it may carry an increased risk of complications associated with thrombosis of major vessels. 25, 26, 27 Some of the studies of MW ablation of lung tumours are summarised in Table 2 . 
Conclusion
